VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $869,000 | -8.5% | 55,400 | 0.0% | 0.09% | -16.2% |
| Q3 2021 | $950,000 | -20.3% | 55,400 | 0.0% | 0.11% | -19.0% |
| Q2 2021 | $1,192,000 | +43.3% | 55,400 | 0.0% | 0.14% | +55.7% |
| Q1 2021 | $832,000 | +1564.0% | 55,400 | +1169.2% | 0.09% | +1157.1% |
| Q2 2020 | $50,000 | -89.6% | 4,365 | -90.6% | 0.01% | -90.0% |
| Q1 2020 | $481,000 | -18.3% | 46,460 | +45.1% | 0.07% | +55.6% |
| Q1 2019 | $589,000 | -24.4% | 32,011 | +7.4% | 0.04% | -28.6% |
| Q4 2018 | $779,000 | -8.4% | 29,800 | -19.5% | 0.06% | +231.6% |
| Q3 2018 | $850,000 | +1.1% | 37,029 | -16.1% | 0.02% | +18.8% |
| Q2 2018 | $841,000 | +13.0% | 44,140 | 0.0% | 0.02% | +14.3% |
| Q1 2018 | $744,000 | +14780.0% | 44,140 | +10935.0% | 0.01% | – |
| Q3 2015 | $5,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |